Sequence Similarity Clusters for the Entities in PDB 1FVV

Entity #1 | Chains: A,C
CYCLIN-DEPENDENT KINASE 2 protein, length: 298 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 345 366 33
95 % 362 383 33 Flexibility: Low
Max RMSD: 7.4, Avg RMSD: 2.2
PDBFlex
90 % 362 383 37
70 % 362 383 45
50 % 390 433 67
40 % 408 465 54
30 % 3720 4367 2
Entity #2 | Chains: B,D
CYCLIN A protein, length: 260 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 69 83 188
95 % 91 105 179 Flexibility: No
Max RMSD: 1.4, Avg RMSD: 0.4
PDBFlex
90 % 95 109 164
70 % 95 109 185
50 % 95 109 228
40 % 95 109 254
30 % 99 115 260

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 2CCH 2 B, D CYCLIN A2 CYCLIN FOLD FRAGMENT RESIDUES 175-432 9606
2 4EOJ 2 B, D Cyclin-A2 C-terminal fragment 9606
3 3DDQ 2 B, D Cyclin-A2 UNP residues 169-430 9913
4 3QHW 2 B, D Cyclin-A2 UNP Residues 163-422 10090
5 4CFV 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 175-432 9606
6 3BHT 2 B, D Cyclin-A2 UNP residues 169-430 9913
7 3TNW 2 B, D Cyclin-A2 cyclin boxes, UNP resdiues 169-430 9913
8 2C5N 2 B, D CYCLIN A2 9606
9 4BCO 2 B, D CYCLIN-A2 9913
10 3MY5 2 B, D Cyclin-A2 UNP residues 169-430 9913
11 3BHV 2 B, D Cyclin-A2 UNP residues 169-430 9913
12 4BCK 2 B, D CYCLIN-A2 RESIDUES 171-432 9606
13 4BCN 2 B CYCLIN-A2 RESIDUES 171-432 9606
14 4BCN 3 D CYCLIN-A2 RESIDUES 171-431 9606
15 4I3Z 2 B, D Cyclin-A2 UNP RESIDUES 105-421 10090
16 2UUE 2 B, D CYCLIN A2 RESIDUES 174-432 9606
17 2IW9 2 B, D CYCLIN-A2 MONOTHIOGLYCEROL ADDUCT ON RESIDUE 193 A3, RESIDUES 174-432 9606
18 4EOP 2 B, D Cyclin-A2 C-terminal fragment 9606
19 4EOI 2 B, D Cyclin-A2 C-terminal fragment 9606
20 5LQF 2 B, E G2/mitotic-specific cyclin-B1 9606
21 1OIU 2 B, D CYCLIN A2 RESIDUES 174-432 9606
22 1VIN 1 A CYCLIN A HIS 6 TAGGED AT C-TERMINUS 9913
23 3QHR 2 B, D Cyclin-A2 UNP Residues 163-422 10090
24 2C5O 2 B, D CYCLIN A2 9606
25 5CYI 2 B, D Cyclin-A2 UNP residues 174-432 9606
26 4CFU 2 B CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 172-432 9606
27 4CFU 3 D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 172-432 9606
28 4EOM 2 B, D Cyclin-A2 C-terminal fragment 9606
29 1H1R 2 B, D CYCLIN A2 9606
30 4II5 2 B, D Cyclin-A2 UNP RESIDUES 165-422 10090
31 4EOQ 2 B, D Cyclin-A2 C-terminal fragment 9606
32 1H1S 2 B, D CYCLIN A2 9606
33 4EOO 2 B, D Cyclin-A2 C-terminal fragment 9606
34 4BCP 2 B, D CYCLIN-A2 RESIDUES 171-432 9606
35 4CFN 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 175-432 9606
36 1H1P 2 B, D CYCLIN A2 9606
37 5HQ0 2 B G2/mitotic-specific cyclin-B1 9606
38 4Y72 2 B G2/mitotic-specific cyclin-B1 9606
39 2WEV 2 B, D CYCLIN-A2 CAP-TETRAPEPTIDE INHIBITOR RESIDUES 173-432 9606
40 1OI9 2 B, D CYCLIN A2 RESIDUES 174-432 9606
41 1JSU 2 B CYCLIN A RESIDUES 173 - 432 9606
42 3BHU 2 B, D Cyclin-A2 UNP residues 169-430 9913
43 1QMZ 2 B, D G2/MITOTIC-SPECIFIC CYCLIN A RESIDUES 174-432 9606
44 4EOR 2 B, D Cyclin-A2 C-terminal fragment 9606
45 1P5E 2 B, D Cyclin A2 residues 175-432 9606
46 2CJM 2 B, D CYCLIN A2 RESIDUES 175-432 9606
47 1H26 2 B, D CYCLIN A2 CYCLIN FOLD, RESIDUES 175-432 9606
48 1FIN 2 B, D CYCLIN A RESIDUES 173 - 432 9606
49 1H27 2 B, D CYCLIN A2 CYCLIN FOLD, RESIDUES 175-432 9606
50 1OKW 2 B, D CYCLIN A2 CYCLIN GROOVE-BOUND PEPTIDE ACE-ARG-ARG-LEU-ASN-FCL-NH2 RESIDUES 173-432 9606
51 2IW8 2 B, D CYCLIN-A2 MONOTHIOGLYCEROL ADDUCT ON RESIDUE 193 A3, RESIDUES 174-432 9606
52 4CFW 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 175-432 9606
53 2UZE 2 B, D CYCLIN A2 RESIDUES 175-432 9606
54 1PKD 2 B, D Cyclin A2 9606
55 1OKV 2 B, D CYCLIN A2 RESIDUES 173 - 432 9606
56 2UZL 2 B, D CYCLIN A2 RESIDUES 175-432 9606
57 2V22 2 B, D CYCLIN-A2 CAP-TETRAPEPTIDE INHIBITOR 9606
58 4BCM 2 B CYCLIN-A2 RESIDUES 171-432 9606
59 4BCM 3 D CYCLIN-A2 RESIDUES 171-432 9606
60 1URC 2 B, D CYCLIN A2 RESIDUES 173 - 432 9606
61 1VYW 2 B, D CYCLIN A2 C-TERMINAL PORTION, RESIDUES 174-432 9606
62 2IW6 2 B, D CYCLIN-A2 MONOTHIOGLYCEROL ADDUCT ON RESIDUE 193 A3, RESIDUES 174-432 9606
63 5LMK 2 B, D Cyclin-A2 9606
64 2WFY 2 B, D CYCLIN-A2 RESIDUES 173-432 9606
65 4BCQ 2 B CYCLIN-A2 RESIDUES 169-429 9913
66 4BCQ 3 D CYCLIN-A2 RESIDUES 169-429 9913
67 4EOL 2 B, D Cyclin-A2 C-terminal fragment 9606
68 4EON 2 B, D Cyclin-A2 C-terminal fragment 9606
69 5IF1 2 B, D Cyclin-A2 9606
70 1OL2 2 B, D CYCLIN A2 RESIDUES 173 - 432 9606
71 1H24 2 B, D CYCLIN A2 CYCLIN FOLD FRAGMENT, RESIDUES 175-432 9606
72 2BPM 2 B, D CYCLIN A2 RESIDUES 174-432 (C-TERMINAL PORTION) 9606
73 2WIH 2 B, D CYCLIN-A2 C-TERMINAL PORTION, RESIDUES 173-432 9606
74 1JST 2 B, D CYCLIN A RESIDUES 173-432 9606
75 1OGU 2 B, D CYCLIN A2 RESIDUES 174-432 9606
76 2C6T 2 B, D CYCLIN A2 RESIDUES 175-432 9606
77 2G9X 2 B, D Cyclin-A2 9913
78 2WPA 2 B, D CYCLIN A2 C-TERMINAL PORTION, RESIDUES 173-432 9606
79 1E9H 2 B, D CYCLIN A3 TRUNCATED FRAGMENT OF CYCLIN A. IN COMPLEX WITH CDK2 CHAINS B AND D ARE ASYMETRIC UNIT COPIES 9606
80 2WXV 2 B, D CYCLIN-A2 C-TERMINAL PORTION, RESIDUES 173-432 9606
81 1OIY 2 B, D CYCLIN A2 RESIDUES 174-432 9606
82 4FX3 2 B, D Cyclin-A2 UNP RESIDUES 175-432 9606
83 3DOG 2 B, D Cyclin-A2 UNP residues 169-430 9913
84 2C5V 2 B, D CYCLIN A2 9606
85 2UZB 2 B, D CYCLIN-A2 RESIDUES 175-432 9606
86 4EOK 2 B, D Cyclin-A2 C-terminal fragment 9606
87 2I40 2 B, D Cyclin-A2 residues 173-432 9606
88 2X1N 2 B, D CYCLIN-A2 RESIDUES 172-432 9606
89 1H1Q 2 B, D CYCLIN A2 9606
90 3DDP 2 B, D Cyclin-A2 UNP residues 169-430 9913
91 4EOS 2 B, D Cyclin-A2 C-terminal fragment 9606
92 2UZD 2 B, D CYCLIN A2 175-432 9606
93 4YC3 2 B G2/mitotic-specific cyclin-B1 N-terminal His tag removed by thrombin cleavage UNP residues 165-433 9606
94 2WHB 2 B, D CYCLIN-A2 RESIDUES 173-432 9606
95 2WMB 2 B, D CYCLIN-A2 RESIDUES 174-432 9606
96 2BKZ 2 B, D CYCLIN A2 RESIDUES 174-432 (C-TERMINAL PORTION) 9606
97 1H25 2 B, D CYCLIN A2 CYCLIN FOLD, RESIDUES 175-432 9606
98 3F5X 2 B, D Cyclin-A2 UNP residues 177-432 9606
99 1FVV 2 B, D CYCLIN A 9606
100 2WMA 2 B, D CYCLIN-A2 RESIDUES 174-432 9606
101 2C5X 2 B, D CYCLIN A2 9606
102 2C4G 2 B, D CYCLIN A2 RESIDUES 173-432 (C-TERMINAL PORTION) 9606
103 2JGZ 2 B G2/MITOTIC-SPECIFIC CYCLIN-B1 RESIDUES 167-426 9606
104 2WIP 2 B, D CYCLIN-A2 C-TERMINAL PORTION, RESIDUES 173-432 9606
105 1OL1 2 B, D CYCLIN A2 RESIDUES 173 - 432 9606
106 4CFM 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 175-432 9606
107 1GY3 2 B, D CYCLIN A2 RESIDUES 175-432 9606
108 5NEV 2 B, D Cyclin-A2 9606
109 3EID 2 B, D Cyclin-A2 UNP residues 173-432 9606
110 1H28 2 B, D CYCLIN A2 CYCLIN FOLD, RESIDUES 175-432 9606
111 2CCI 2 B, D Cyclin-A2 RESIDUES 175-432 9606
112 3EOC 2 B, D Cyclin-A2 Proteolytic fragment: Residues 173-432 9606
113 2B9R 1 A, B Human cyclin B1 Residues 165-433 9606
114 3EJ1 2 B, D Cyclin-A2 UNP residues 113-432 9606
115 4CFX 2 B, D CYCLIN-A2 CDK-ACTIVATING FRAGMENT, RESIDUES 173-432 9606